Tradestie Institutional Equity Comparison Engine
BBLG vs NMAD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMAD Overall Edge
NMAD Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NMAD (NMAD) driven by superior Momentum & Technical, Options & Structure while BBLG counters with relative strength in Growth & Margin. Fundamentally, BBLG trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NMAD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BBLG sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against NMAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BBLG N/M vs NMAD N/M Fwd P/E
Growth & Margin Winner
BBLG
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
NMAD
1Y -82.9% vs -65.1% ยท 52W Pos 0% vs 8%
Options & Structure Winner
NMAD
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
BBLG
NASDAQ
Bone Biologics Corp Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.27
-2.4% 1D
Market Cap
$932,329
1M Return
-33.8%
1Y Return
-82.9%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 33.0
Fund 48.0
Flow 50.0
Mom 64.0
NMAD
US Equity
NMAD
Institutional Equity
$2.56
+13.53% 1D
Market Cap
N/A
1M Return
-28.89%
1Y Return
-65.12%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BBLG -82.9%
NMAD -65.12%
Spread: +16.23 pp (NMAD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BBLG TTM Op. Margin: 0.0%
NMAD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBLG vs NMAD. Trailing 12-month operating profitability (BBLG 0.0% vs NMAD N/A) and valuation multiples (BBLG N/M vs NMAD N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BBLG | NMAD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $932,329 | N/A | Larger Scale | BBLG |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | BBLG |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | BBLG |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | BBLG |
| Return on Equity (ROE) Capital Efficiency | -47.5% | N/A | Higher ROE | BBLG |
| 52-Week Range Position Momentum | 0% ($0โ$2) | 8% ($2โ$8) | Stronger Trend | NMAD |
| Beta / 30D Volatility Risk Regime | 0.97ฮฒ ยท 102% Vol | 0.52ฮฒ ยท 173% Vol | Lower Realized Risk | BBLG |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 47.9 / 100 (HOLD) | Higher Composite | NMAD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BBLG vs NMAD Buy Guide
BBLG
BREAKDOWN
104d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NMAD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BBLG nor NMAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.